ArticleJournal of chemical information and modeling2026
Controllable Protein Design by Prefix-Tuning Protein Language Models.
Article in Journal of chemical information and modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Reinforcement learning with low-rank adaptation for targeted antimicrobial peptide design.Briefings in bioinformatics · 2025Article
- Bioengineering approaches to trained immunity: Physiologic targets and therapeutic strategies.eLife · 2025Review
- Leveraging large language models for peptide antibiotic design.Cell reports. Physical science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The design of novel proteins with tailored functionalities presents a transformative approach to addressing pressing biomedical challenges. In this study, we propose PrefixProt, a framework for controllable protein design that employs prefix-tuning to learn virtual tokens as control tags. These virtual tokens are adaptively tailored to diverse protein properties through a data-driven manner and can be combinatorially integrated to enable multiobjective control over protein generation. The effectiveness of PrefixProt was validated through extensive experiments encompassing both protein structure design (e.g., α helix or beta-sheet topologies) and protein function design (e.g., antimicrobial or anticancer peptide activities). Benchmark results demonstrate that prefix virtual tokens efficiently guide the pretrained ProtLM by optimizing a smaller number of trainable parameters, outperforming other parameter-efficient fine-tuning methods and text-guided ProtLMs, particularly in scenarios with limited data availability. More importantly, the compositional flexibility of virtual tokens facilitates the generation of proteins with multiple target properties, substantially expanding the scope of the design possibilities. PrefixProt establishes a robust framework for de novo protein design with promising applications in drug discovery and biomedicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.